The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Sex-specific trends and outcomes in small cell lung cancer (SCLC) in Spain: Insights from the CLARISSE study (2019–2024).
 
Pilar Garrido
Employment - Teva (I)
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Bayer; BeiGene; Boehringer Ingelheim Spain; Bristol-Myers Squibb/Medarex; Daiichi Sankyo Europe GmbH; Gebro Pharma (I); GlaxoSmithKline; IO Biotech; Janssen Oncology; MSD Oncology; Nordic Group (I); Novartis; Pfizer; PharmaMar; Pierre Fabre; Regeneron; Roche Pharma AG; Sanofi
Speakers' Bureau - Amgen; AstraZeneca; Daiichi Sankyo Europe GmbH; Johnson & Johnson/Janssen; Lilly; Pfizer
Travel, Accommodations, Expenses - AstraZeneca Spain; Johnson & Johnson/Janssen; Pfizer
Other Relationship - IO Biotech; Novartis
 
Noemí­ Villanueva
No Relationships to Disclose
 
Reyes Bernabé
Consulting or Advisory Role - Bristol-Myers Squibb; MSD; Roche
Research Funding - Roche
 
Rosario Campelo
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Janssen Oncology; MSD Oncology; Novartis; Pfizer; Roche/Genentech; Takeda
Speakers' Bureau - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Janssen Oncology; Lilly; MSD Oncology; Novartis; Pfizer; Roche; Sanofi/Aventis; Takeda
Travel, Accommodations, Expenses - MSD Oncology; Pfizer; Roche/Genentech
 
Maria Sala
Consulting or Advisory Role - Pierre Fabre; Roche
Speakers' Bureau - Deciphera; Pfizer
Travel, Accommodations, Expenses - AstraZeneca; PharmaMar; Pzifer,; Roche
 
Helena Bote-de Cabo
Speakers' Bureau - AstraZeneca; Johnson & Johnson/Janssen
Travel, Accommodations, Expenses - Johnson & Johnson/Janssen; Roche
 
Maria Amelia Insa Molla
Speakers' Bureau - AstraZeneca; BeOne Medicines; Roche; Takeda
Expert Testimony - AstraZeneca; MSD; Roche; Takeda
Travel, Accommodations, Expenses - MSD; Pfizer; Roche; Takeda
 
Ruth Alvarez
Travel, Accommodations, Expenses - Merck Animal Health; Pfizer; Roche
 
Patricia Cruz
No Relationships to Disclose
 
Margarita Majem
Consulting or Advisory Role - AstraZeneca; BeiGene Beijing; Boehringer Ingelheim; Bristol-Myers Squibb; Helsinn Therapeutics; Janssen Oncology; Merck Sharp & Dohme; Novartis; Pfizer; Pierre Fabre; Roche; Sanofi; Takeda
Research Funding - AstraZeneca (Inst); BMS (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; MSD Oncology; Pfizer; Roche
 
María Angeles Moreno Santos
Consulting or Advisory Role - AstraZeneca; Merck
Speakers' Bureau - AstraZeneca; Merck
Travel, Accommodations, Expenses - MSD; Pfizer
 
Marta González Cordero
No Relationships to Disclose
 
Juana Maria Oramas Rodriguez
Travel, Accommodations, Expenses - GlaxoSmithKline; Pfizer; Roche
 
Rosa Alvarez Alvarez
Consulting or Advisory Role - Boehringer Ingelheim; Roche/Genentech; SpringWorks Therapeutics
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); CEBIOTEX (Inst); Cogent Medicine (Inst); Daiichi Sankyo/Astra Zeneca (Inst); GlaxoSmithKline (Inst); Janssen Oncology (Inst); MSD Oncology (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst); PharmaMar (Inst); Philogen (Inst); Rain Therapeutics (Inst); Roche/Genentech (Inst); SpringWorks Therapeutics (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Deciphera; MSD Oncology; PharmaMar; Roche
 
Beatriz Alvarez-Abril
Speakers' Bureau - BeOne Medicines; MSD; Pfizer
Travel, Accommodations, Expenses - Johnson & Johnson; Roche
 
Laura Gutiérrez-Sainz
No Relationships to Disclose
 
Vanesa Gutiérrez
No Relationships to Disclose
 
Nerea Munoz-Unceta
No Relationships to Disclose
 
Enriqueta Felip
Honoraria - Amgen; Daiichi Sankyo Europe GmbH; Gilead Sciences; Janssen / Johnson & Johnson; Lilly; MSD; Pfizer; Roche
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Boehringer Ingelheim; Bristol Myers Squibb; Daiichi Sankyo Europe GmbH; Genentech/Roche; GlaxoSmithKline; ITeos Therapeutics; Johnson & Johnson/Janssen; Merck Sharp & Dohme; Pfizer; PharmaMar; Pierre Fabre; Regeneron; Seagen; Tubulis GmbH
Other Relationship - GRIFOLS
(OPTIONAL) Uncompensated Relationships - "ETOP IBCSG Partners" Member of the Scientific Committee; Member of the Scientific Advisory Committee -Hospital Universitari Parc Taulí-; SEOM (Sociedad Española de Oncología Médica), President from 2021-2023
 
Dolores Isla
Honoraria - AMGEN; AstraZeneca; BMS; Merck; MSD Oncology; Novartis; Pfizer; Roche/Genentech; Sanofi
Consulting or Advisory Role - AMGEN; AstraZeneca; BMS; GlaxoSmithKline; Janssen; MSD; Sanofi
Speakers' Bureau - AstraZeneca; BMS; JANSSEN; Lilly; MERCK; MSD; NOVARTIS; Pfizer; Roche; Sanofi
Travel, Accommodations, Expenses - AstraZeneca; MSD; Pfizer; Roche/Genentech